Santhera Publishes Agenda for its Annual General Meeting

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Ad hoc announcement...

Related Keywords

France ,Pratteln ,Switzerland General ,Switzerland ,United States ,United Kingdom ,Swiss ,America ,Thomas Meier ,Patrick Vink ,Otto Schwarz ,Bradleyc Meyer ,Eva Kalias ,Philipp Gutzwiller ,Head Investor Relations Communications ,Santhera Pharmaceuticals ,Compensation Committee ,Santhera Pharmaceuticals Holding ,Regulatory Agency ,European Medicines Agency ,Actelion Pharmaceuticals Ltd ,Chiesi Group ,Idorsia Pharmaceuticals Ltd ,Annual General Meeting ,Executive Committee ,Ducera Partners ,Actelion Pharmaceuticals ,Managing Director ,Concentus Consulting ,Annual Report ,Annual Financial Statements ,Consolidated Financial Statements ,Annual Result ,Compensation Report ,Executive Management ,Financial Year ,Financing Purposes ,Employee Participations ,Independent Proxy ,United Kingdom Medicines ,North America ,Head Investor Relations ,Securities Act ,Swiss Stock Exchange Sann ,Santhera Pharmaceuticals Holding Ag ,